Vanberra Signal

Peaccel

Curated by Signal

Computational platform and services for protein engineering

Overview

Peaccel is a bioinformatics company developing computational tools for the rational design of proteins for various applications, in silico screening of mutant libraries, and designing of synthetic biochemical pathways. The company's areas of expertise include evolutionary analysis of protein sequences, sequence divergence, ancestral gene reconstruction, protein structure analysis and modeling, computational screening of mutant libraries to enable rational protein design. At the core of its services, are Peaccel's iMutate in silico mutagenesis platform, and its statistical modeling for protein engineering (Peaccel Platform).

Key facts

Founded
2011
Headquarters
Paris, France

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of cloud-based lab management collaborative platform

    Health TechnologyNeuilly sur seine, France
  • Provider of a digital therapeutics platform for neurodevelopmental disorders

    Health TechnologyPalaiseau, France
  • Online surgical training and education tool for providers

    Health TechnologyStrasbourg, France

About Peaccel

What does Peaccel do?

Peaccel is a bioinformatics company developing computational tools for the rational design of proteins for various applications, in silico screening of mutant libraries, and designing of synthetic biochemical pathways.

Where is Peaccel headquartered?

Peaccel is headquartered in Paris, France.

When was Peaccel founded?

Peaccel was founded in 2011.

Which sector is Peaccel in?

Peaccel operates in Health Technology.

Who are Peaccel's competitors?

Companies similar to Peaccel include Keralia, Poppins, and InSimo.